Daniel Sundheim’s Boston Scientific BSX Stock Holding History

Daniel Sundheim’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000,000	Closed	-$38.7M	–	32
2022 Q3	$38.7M	Buy	+1,000,000	New	+$40.1M	0.71%	29

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Daniel Sundheim's BSX Position: Q4 2022 in Review

Daniel Sundheim sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 1,000,000 shares — an estimated $38.7M sold.

Daniel Sundheim first reported a position in BSX in Q3 2022 and held it in 1 quarter. The position peaked at $38.7M in Q3 2022. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Daniel Sundheim reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
Daniel Sundheim sold 1,000,000 Boston Scientific shares in Q4 2022, an estimated $38.7M.
Daniel Sundheim first reported a position in Boston Scientific in Q3 2022 and held it in 1 quarter.
Daniel Sundheim's Boston Scientific position peaked at $38.7M in Q3 2022.
929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on D1 Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.